| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.03 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |